Smooth Drug Development April 2025 News Release

Monthly News – April 2025

At Smooth Drug Development, we are excited to share the latest updates and achievements from April 2025:

New Projects

We are delighted to announce several new collaborations and ongoing initiatives:

• Contract signed to conduct a BE trial with Ataluren.
• Contract prepared for a Phase I trial with Laronidase in Belarus.
• Agreement signed for medical writing services for a Phase IV trial with Vamotinib.

Clinical and Scientific Departments News:

Our clinical teams continue to deliver outstanding progress:

• Enrollment completed in the Pembrolizumab trial.
• 50% of patients included in the Cetirizine trial.

Business Development News:

Our Business Development team has been actively engaging in discussions, collaborations, and attending key conferences:

• Attended the World Vaccine Congress 2025 in Washington, D.C., meeting with clients and U.S.-based Site Management Organizations (SMOs).
• Exploring opportunities to expand CRO services in the U.S. market through new partnerships.
• Participated in the XII All-Russian Conference on preclinical and clinical studies.